A. van den Ende

1.7k total citations
42 papers, 1.4k citations indexed

About

A. van den Ende is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Hematology. According to data from OpenAlex, A. van den Ende has authored 42 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Endocrinology, Diabetes and Metabolism, 9 papers in Surgery and 7 papers in Hematology. Recurrent topics in A. van den Ende's work include Hormonal and reproductive studies (8 papers), Lipoproteins and Cardiovascular Health (7 papers) and Blood Coagulation and Thrombosis Mechanisms (4 papers). A. van den Ende is often cited by papers focused on Hormonal and reproductive studies (8 papers), Lipoproteins and Cardiovascular Health (7 papers) and Blood Coagulation and Thrombosis Mechanisms (4 papers). A. van den Ende collaborates with scholars based in Netherlands, Russia and Canada. A. van den Ende's co-authors include Sander J. H. van Deventer, P. R. Abraham, J.H.M. Levels, Dirk de Korte, W.J.A. Dekker, J.A. Loos, A. van Enk, M. De Jong‐Bakker, Andrew Hart and Dasja Pajkrt and has published in prestigious journals such as Blood, The Journal of Immunology and Analytical Biochemistry.

In The Last Decade

A. van den Ende

40 papers receiving 1.3k citations

Peers

Countries citing papers authored by A. van den Ende

Since Specialization

Citations

This map shows the geographic impact of A. van den Ende's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. van den Ende with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. van den Ende more than expected).

Fields of papers citing papers by A. van den Ende

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. van den Ende. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. van den Ende. The network helps show where A. van den Ende may publish in the future.

Co-authorship network of co-authors of A. van den Ende

This figure shows the co-authorship network connecting the top 25 collaborators of A. van den Ende. A scholar is included among the top collaborators of A. van den Ende based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. van den Ende. A. van den Ende is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Experience in the long-term treatment of patients with hirsutism and/or acne with cyproterone acetate-containing preparations: Efficacy, metabolic and endocrine effects 2009 ·Experimental and Clinical Endocrinology & Diabetes ·(unknown), A. van den Ende	12
2	PROTHROMBIN 20210 G: A MUTATION AND FACTOR V LEIDEN MUTATION IN WOMEN WITH A HISTORY OF SEVERE PREECLAMPSIA AND (H)ELLP SYNDROME* 2001 ·Hypertension in Pregnancy ·Maria G. van Pampus, Hans Wolf, Maria M.W. Koopman, A. van den Ende, Harry R. Büller, Pieter H. Reitsma	12
3	The 20210 G → A mutation in the 3′‐untranslated region of the prothrombin gene and the risk for arterial thrombotic disease 1999 ·British Journal of Haematology ·Rendrik F. Franco, Mieke D. Trip, Hugo Ten Cate, A. van den Ende, Martin H. Prins, John J.P. Kastelein, P.H. Reitsma	88
4	Magnesium pyridoxal-5′-phosphate glutamate, "A vitamin B 6 derivative", does not affect lipoprotein levels in patients with familial hypercholesterolaemia 1997 ·European Journal of Clinical Pharmacology ·H.C. Knipscheer, Iris Kindt, A. van den Ende, Michael T. Nurmohamed, (unknown), Willem J. M. Mulder, John J.P. Kastelein	4
5	Interleukin-10 Inhibits Activation of Coagulation and Fibrinolysis During Human Endotoxemia 1997 ·Blood ·Dasja Pajkrt, Tom van der Poll, Marcel Levi, David L. Cutler, Melton B. Affrime, A. van den Ende, Jan W. ten Cate, Sander J. H. van Deventer	125
6	A randomized cross-over study comparing pharmacodynamic and metabolic variables of a new combiphasic and a well-established triphasic oral contraceptive 1997 ·The European Journal of Contraception & Reproductive Health Care ·A. van den Ende, T. B. Paul Geurts, H.J. Kloosterboer	7
7	Short-Term Efficacy and Safety of Pravastatin in 72 Children with Familial Hypercholesterolemia 1996 ·Pediatric Research ·H.C. Knipscheer, C Boelen, J Kastelein, D.E. van Diermen, Björn E. Groenemeijer, A. van den Ende, Harry R. Büller, H. D. Bakker	124
8	Lipoprotein [a] 1996 ·Advances in clinical chemistry ·A. van den Ende, Ytje Y. van der Hoek, J Kastelein, Marlys L. Koschinsky, (unknown), (unknown)	6
9	Serum distribution of two contraceptive progestins: 3-ketodesogestrel and gestodene 1994 ·Contraception ·Geoffrey L. Hammond, Wayne P. Bocchinfuso, Mauri Orava, C. Smith, A. van den Ende, A. van Enk	7
10	Gemfibrozil treatment of the high triglyceride‐low high‐density lipoprotein cholesterol trait in men with established atherosclerosis 1994 ·Journal of Internal Medicine ·H.C. Knipscheer, Michael T. Nurmohamed, A. van den Ende, Boudewijn E. C. Plaat, (unknown), Willem J. M. Mulder, John J.P. Kastelein	8
11	The Effect of Two Regimens of Hormone Replacement Therapy on the Haemostatic Profile in Postmenopausal Women 1994 ·Clinical Chemistry and Laboratory Medicine (CCLM) ·J. W. J. van Wersch, J.M.H. Ubachs, A. van den Ende, (unknown)	40
12	Evaluation of blood sampling for the measurement of tissue-type plasminogen activator (t-PA) and plasminogen activator inhibitor activity (PAI-1) 1994 ·Fibrinolysis and Proteolysis ·(unknown), (unknown), A. van den Ende	1
13	Bone mineral density after adjuvant chemotherapy for premenopausal breast cancer 1990 ·British Journal of Cancer ·(unknown), (unknown), M. De Jong‐Bakker, A. van den Ende, Andrew Hart, A. van Enk	144
14	Storage of Whole Blood for up to 24 Hours at Ambient Temperature prior to Component Preparation 1989 ·Vox Sanguinis ·(unknown), Dirk de Korte, Hendrik W. Reesink, W.J.A. Dekker, A. van den Ende, J.A. Loos	138
15	Storage of Leukocyte‐Poor Red Cell Concentrates: Filtration in a Closed System Using a Sterile Connection Device 1989 ·Vox Sanguinis ·R. N. I. Pietersz, H. W. Reesink, Dirk de Korte, (unknown), A. van den Ende, J.A. Loos	36
16	Preparation of Leukocyte‐Poor Platelet Concentrates from Buffy Coats 1988 ·Vox Sanguinis ·(unknown), Dirk de Korte, H. W. Reesink, A. van den Ende, W.J.A. Dekker, Dirk Roos	60
17	Determination of urinary cystine for monitoring anticystinuric therapy 1987 ·Clinica Chimica Acta ·(unknown), A. van den Ende, (unknown)	3
18	Pharmacokinetics of transdermally delivered clonidine 1985 ·Clinical Pharmacology & Therapeutics ·Thomas R. MacGregor, Kandace M. Matzek, James J. Keirns, (unknown), A. van den Ende, (unknown)	43
19	Effect of cyproterone acetate on pituitary-adrenocortical function in man 1981 ·European Journal of Endocrinology ·(unknown), A. van den Ende	4
20	Conductometric titration of hydrochloric acid in gastric juice. 1980 ·Clinical Chemistry ·Anton P. van Zanten, A. van den Ende	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact